Matching Patients to Clinical Trials with Large Language Models.

ArXiv Pub Date : 2024-04-27
Qiao Jin, Zifeng Wang, Charalampos S Floudas, Fangyuan Chen, Changlin Gong, Dara Bracken-Clarke, Elisabetta Xue, Yifan Yang, Jimeng Sun, Zhiyong Lu
{"title":"Matching Patients to Clinical Trials with Large Language Models.","authors":"Qiao Jin, Zifeng Wang, Charalampos S Floudas, Fangyuan Chen, Changlin Gong, Dara Bracken-Clarke, Elisabetta Xue, Yifan Yang, Jimeng Sun, Zhiyong Lu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Clinical trials are often hindered by the challenge of patient recruitment. In this work, we introduce TrialGPT, a first-of-its-kind large language model (LLM) framework to assist patient-to-trial matching. Given a patient note, TrialGPT predicts the patient's eligibility on a criterion-by-criterion basis and then consolidates these predictions to assess the patient's eligibility for the target trial. We evaluate the trial-level prediction performance of TrialGPT on three publicly available cohorts of 184 patients with over 18,000 trial annotations. We also engaged three physicians to label over 1,000 patient-criterion pairs to assess its criterion-level prediction accuracy. Experimental results show that TrialGPT achieves a criterion-level accuracy of 87.3% with faithful explanations, close to the expert performance (88.7%-90.0%). The aggregated TrialGPT scores are highly correlated with human eligibility judgments, and they outperform the best-competing models by 32.6% to 57.2% in ranking and excluding clinical trials. Furthermore, our user study reveals that TrialGPT can significantly reduce the screening time (by 42.6%) in a real-life clinical trial matching task. These results and analyses have demonstrated promising opportunities for clinical trial matching with LLMs such as TrialGPT.</p>","PeriodicalId":8425,"journal":{"name":"ArXiv","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418514/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ArXiv","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Clinical trials are often hindered by the challenge of patient recruitment. In this work, we introduce TrialGPT, a first-of-its-kind large language model (LLM) framework to assist patient-to-trial matching. Given a patient note, TrialGPT predicts the patient's eligibility on a criterion-by-criterion basis and then consolidates these predictions to assess the patient's eligibility for the target trial. We evaluate the trial-level prediction performance of TrialGPT on three publicly available cohorts of 184 patients with over 18,000 trial annotations. We also engaged three physicians to label over 1,000 patient-criterion pairs to assess its criterion-level prediction accuracy. Experimental results show that TrialGPT achieves a criterion-level accuracy of 87.3% with faithful explanations, close to the expert performance (88.7%-90.0%). The aggregated TrialGPT scores are highly correlated with human eligibility judgments, and they outperform the best-competing models by 32.6% to 57.2% in ranking and excluding clinical trials. Furthermore, our user study reveals that TrialGPT can significantly reduce the screening time (by 42.6%) in a real-life clinical trial matching task. These results and analyses have demonstrated promising opportunities for clinical trial matching with LLMs such as TrialGPT.

Abstract Image

Abstract Image

Abstract Image

用大型语言模型将患者与临床试验相匹配。
临床试验对推进药物开发和循证医学至关重要,但其成功往往受到患者招募挑战的阻碍。在这项工作中,我们研究了大型语言模型(LLM)的潜力,以帮助个体患者和转诊医生从广泛的选择中确定合适的临床试验。具体来说,我们介绍了TrialGPT,这是一种新的架构,使用LLM来预测标准级别的合格性,并提供详细的解释,然后根据免费文本患者笔记对这些解释进行汇总,以对候选临床试验进行排名和排除。我们在三个公开的184名患者队列和18238项注释临床试验中评估了TrialGPT。实验结果证明了几个关键发现:首先,TrialGPT通过忠实的解释实现了高标准级的预测精度。其次,综合试验水平的TrialGPT分数与专家资格注释高度相关。第三,这些分数被证明可以有效地对临床试验进行排名,并排除不合格的候选人。我们的错误分析表明,由于医学知识和特定领域的上下文理解有限,目前的LLM仍然会犯一些错误。尽管如此,我们相信LLM的解释能力是非常有价值的。未来有必要研究如何将此类人工智能助手集成到现实世界环境中的常规试验匹配工作流程中,以提高其效率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信